The Golden Triangle and the gaps: Rethinking UK biotech
From BioSpace · · 19 min
This plays from the publisher's own server. We do not host a copy.
Description
In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you’ll hear from Hakan Goker, managing director at M Ventures and Maina Bhaman, partner at Sofinnova Partners. We explore the UK biotech ecosystem : from the Golden Triangle’s evolving role to the challenges of scaling companies, unlocking pension capital and staying globally competitive.
Host
Jennifer C. Smith-Parker (https://www.linkedin.com/in/jennifersmithparker/), Director of Insights, BioSpace
Guests
Hakan Goker (https://www.linkedin.com/in/hakan-goker-a61a674/), Managing Director, M Ventures
Maina Bhaman (https://www.linkedin.com/in/maina-bhaman-b7a229/), Partner, Sofinnova Partners
Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.